<DOC>
	<DOCNO>NCT02041208</DOCNO>
	<brief_summary>The purpose study e determine hemoglobin variability kidney transplant recipient chronic renal anemia .</brief_summary>
	<brief_title>Variability Hemoglobin Levels After Kidney Transplantation</brief_title>
	<detailed_description>The primary endpoint study hemoglobin level variability . For determination variability , follow pattern hemoglobin level change establish : - Target range hemoglobin ( TRH ) : patient hemoglobin value range 11.0-12.0g/dl throughout study period . - Low hemoglobin ( LH ) : patient level 11.0g/dl - High hemoglobin ( HH ) : patient level 12.0g/dl - Low-amplitude fluctuation low hemoglobin ( LALH ) : patient least one measurement hemoglobin level &lt; 11.0g/dl least one measurement range 11.0-12.0g/dl , without hemoglobin measurement &gt; 12.0g/dl . - Low-amplitude fluctuation high hemoglobin ( LAHH ) : patient least one measurement hemoglobin level &gt; 12.0g/dl least one measurement range 11.0-12.0g/dl , without hemoglobin measurement &lt; 11.0g/dl . - High-amplitude fluctuation ( HAH ) : patient least one measurement hemoglobin level &lt; 11.0g/dl least one measurement &gt; 12.0g/dl . Secondary objective : - To determine potential factor influence hemoglobin variability . - To assess influence hemoglobin variability cardiovascular risk patient accord REGICOR function end study period .</detailed_description>
	<mesh_term>Anemia</mesh_term>
	<criteria>Patients age &gt; = 18 year . Kidney transplant recipient chronic renal failure stage 3 ( glomerular filtration rate : 3059ml/min/1.73m2 ) , 4 ( glomerular filtration rate : 1529ml/min/1.73m2 ) 5 ( glomerular filtration rate : &lt; 15ml/min/1.73m2 ) start study followup period . Diagnosis anemia drug treatment initiate change subsequent June 29 , 2010 ( date late recommendation European Renal Best Practice target range hemoglobin level publish ) Patients capable give informed consent participate study agree participate signing informed consent form . Patients whose medical history lack measurement hemoglobin level every three month ( Â±1 month ) year study followup .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2014</verification_date>
	<keyword>Chronic renal anemia</keyword>
	<keyword>Hemoglobin</keyword>
	<keyword>Kidney transplant</keyword>
</DOC>